<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v2.0 20040830//EN" "journalpublishing.dtd"><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="2.0" xml:lang="en" article-type="research-article"><front><journal-meta><journal-id journal-id-type="nlm-ta">JMIR Cancer</journal-id><journal-id journal-id-type="publisher-id">cancer</journal-id><journal-id journal-id-type="index">21</journal-id><journal-title>JMIR Cancer</journal-title><abbrev-journal-title>JMIR Cancer</abbrev-journal-title><issn pub-type="epub">2369-1999</issn><publisher><publisher-name>JMIR Publications</publisher-name><publisher-loc>Toronto, Canada</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">v11i1e53328</article-id><article-id pub-id-type="doi">10.2196/53328</article-id><article-categories><subj-group subj-group-type="heading"><subject>Original Paper</subject></subj-group></article-categories><title-group><article-title>Assessing Public Interest in Mammography, Computed Tomography Lung Cancer Screening, and Computed Tomography Colonography Screening Examinations Using Internet Search Data: Cross-Sectional Study</article-title></title-group><contrib-group><contrib contrib-type="author"><name name-style="western"><surname>Zippi</surname><given-names>Zachary D</given-names></name><degrees>PharmD</degrees><xref ref-type="aff" rid="aff1">1</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Cortopassi</surname><given-names>Isabel O</given-names></name><degrees>MD</degrees><xref ref-type="aff" rid="aff2">2</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Grage</surname><given-names>Rolf A</given-names></name><degrees>MD</degrees><xref ref-type="aff" rid="aff2">2</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Johnson</surname><given-names>Elizabeth M</given-names></name><degrees>MD</degrees><xref ref-type="aff" rid="aff2">2</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>McCann</surname><given-names>Matthew R</given-names></name><degrees>MD</degrees><xref ref-type="aff" rid="aff2">2</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Mergo</surname><given-names>Patricia J</given-names></name><degrees>MD</degrees><xref ref-type="aff" rid="aff2">2</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Sonavane</surname><given-names>Sushil K</given-names></name><degrees>MD</degrees><xref ref-type="aff" rid="aff2">2</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Stowell</surname><given-names>Justin T</given-names></name><degrees>MD</degrees><xref ref-type="aff" rid="aff2">2</xref></contrib><contrib contrib-type="author" corresp="yes"><name name-style="western"><surname>Little</surname><given-names>Brent P</given-names></name><degrees>MD</degrees><xref ref-type="aff" rid="aff2">2</xref></contrib></contrib-group><aff id="aff1"><institution>Florida International University College of Medicine</institution><addr-line>Miami</addr-line><addr-line>FL</addr-line><country>United States</country></aff><aff id="aff2"><institution>Mayo Clinic College of Medicine and Science, Mayo Clinic Florida</institution><addr-line>4500 San Pablo Road</addr-line><addr-line>Jacksonville</addr-line><addr-line>FL</addr-line><country>United States</country></aff><contrib-group><contrib contrib-type="editor"><name name-style="western"><surname>Cahill</surname><given-names>Naomi</given-names></name></contrib></contrib-group><contrib-group><contrib contrib-type="reviewer"><name name-style="western"><surname>Lampridis</surname><given-names>Savvas</given-names></name></contrib><contrib contrib-type="reviewer"><name name-style="western"><surname>Tiryaki</surname><given-names>Volkan Mujdat</given-names></name></contrib></contrib-group><author-notes><corresp>Correspondence to Brent P Little, MD, Mayo Clinic College of Medicine and Science, Mayo Clinic Florida, 4500 San Pablo Road, Jacksonville, FL, 32224, United States, 1 904-953-0853; <email>little.brent@mayo.edu</email></corresp></author-notes><pub-date pub-type="collection"><year>2025</year></pub-date><pub-date pub-type="epub"><day>11</day><month>3</month><year>2025</year></pub-date><volume>11</volume><elocation-id>e53328</elocation-id><history><date date-type="received"><day>03</day><month>10</month><year>2023</year></date><date date-type="rev-recd"><day>23</day><month>01</month><year>2025</year></date><date date-type="accepted"><day>30</day><month>01</month><year>2025</year></date></history><copyright-statement>&#x00A9; Zachary D Zippi, Isabel O Cortopassi, Rolf A Grage, Elizabeth M Johnson, Matthew R McCann, Patricia J Mergo, Sushil K Sonavane, Justin T Stowell, Brent P Little. Originally published in JMIR Cancer (<ext-link ext-link-type="uri" xlink:href="https://cancer.jmir.org">https://cancer.jmir.org</ext-link>), 11.3.2025. </copyright-statement><copyright-year>2025</copyright-year><license license-type="open-access" xlink:href="https://creativecommons.org/licenses/by/4.0/"><p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (<ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">https://creativecommons.org/licenses/by/4.0/</ext-link>), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work, first published in JMIR Cancer, is properly cited. The complete bibliographic information, a link to the original publication on <ext-link ext-link-type="uri" xlink:href="https://cancer.jmir.org/">https://cancer.jmir.org/</ext-link>, as well as this copyright and license information must be included.</p></license><self-uri xlink:type="simple" xlink:href="https://cancer.jmir.org/2025/1/e53328"/><abstract><sec><title>Background</title><p>The noninvasive imaging examinations of mammography (MG), low-dose computed tomography (CT) for lung cancer screening (LCS), and CT colonography (CTC) play important roles in screening for the most common cancer types. Internet search data can be used to gauge public interest in screening techniques, assess common screening-related questions and concerns, and formulate public awareness strategies.</p></sec><sec><title>Objective</title><p>This study aims to compare historical Google search volumes for MG, LCS, and CTC and to determine the most common search topics.</p></sec><sec sec-type="methods"><title>Methods</title><p>Google Trends data were used to quantify relative Google search frequencies for these imaging screening modalities over the last 2 decades. A commercial search engine tracking product (keywordtool.io) was used to assess the content of related Google queries over the year from May 1, 2022, to April 30, 2023, and 2 authors used an iterative process to agree upon a list of thematic categories for these queries. Queries with at least 10 monthly instances were independently assigned to the most appropriate category by the 2 authors, with disagreements resolved by consensus.</p></sec><sec sec-type="results"><title>Results</title><p>The mean 20-year relative search volume for MG was approximately 10-fold higher than for LCS and 25-fold higher than for CTC. Search volumes for LCS have trended upward since 2011. The most common topics of MG-related searches included nearby screening locations (60,850/253,810, 24%) and inquiries about procedural discomfort (28,970/253,810, 11%). Most common LCS-related searches included CT-specific inquiries (5380/11,150, 48%) or general inquiries (1790/11,150, 16%), use of artificial intelligence or deep learning (1210/11,150, 11%), and eligibility criteria (1020/11,150, 9%). For CTC, the most common searches were CT-specific inquiries (1800/5590, 32%) or procedural details (1380/5590, 25%).</p></sec><sec sec-type="conclusions"><title>Conclusions</title><p>Over the past 2 decades, Google search volumes have been significantly higher for MG than for either LCS or CTC, although search volumes for LCS have trended upward since 2011. Knowledge of public interest and queries related to imaging-based screening techniques may help guide public awareness efforts.</p></sec></abstract><kwd-group><kwd>lung cancer</kwd><kwd>lung cancer screening</kwd><kwd>breast cancer</kwd><kwd>mammography</kwd><kwd>colon cancer</kwd><kwd>CT colonography</kwd><kwd>Google search</kwd><kwd>internet</kwd><kwd>Google Trends</kwd><kwd>imaging-based</kwd><kwd>cancer screening</kwd><kwd>search data</kwd><kwd>noninvasive</kwd><kwd>cancer</kwd><kwd>CT</kwd><kwd>online</kwd><kwd>public awareness</kwd><kwd>big data</kwd><kwd>analytics</kwd><kwd>patient education</kwd><kwd>screening uptake</kwd></kwd-group></article-meta></front><body><sec id="s1" sec-type="intro"><title>Introduction</title><p>Worldwide, an estimated 20 million new cancer diagnoses and 9.7 million deaths occurred in 2022. The 3 most common types of newly diagnosed malignancies were lung cancer (12.4%), female breast cancer (11.6%), and colorectal cancer (9.6%). Lung cancer and colorectal cancer were the most common causes of cancer-related mortality, with breast cancer in fourth place after liver cancer [<xref ref-type="bibr" rid="ref1">1</xref>]. Noninvasive imaging, such as mammography (MG), low-dose computed tomography (CT) for lung cancer screening (LCS), and CT colonography (CTC), plays important roles in the early detection of the most common cancer types and has demonstrated efficacy in reducing cancer-related and all-cause mortality rates [<xref ref-type="bibr" rid="ref2">2</xref>,<xref ref-type="bibr" rid="ref3">3</xref>]. Encouraging results from large screening trials in several countries [<xref ref-type="bibr" rid="ref4">4</xref>-<xref ref-type="bibr" rid="ref6">6</xref>] have driven global interest in imaging-based lung, breast, and colorectal screening [<xref ref-type="bibr" rid="ref7">7</xref>-<xref ref-type="bibr" rid="ref12">12</xref>] and have prompted efforts to initiate and optimize screening worldwide [<xref ref-type="bibr" rid="ref13">13</xref>-<xref ref-type="bibr" rid="ref15">15</xref>].</p><p>A 2013 Pew Research Center survey found that 72% of adults had pursued web-based health information over the past year, with 77% performing an initial search using an internet search engine [<xref ref-type="bibr" rid="ref16">16</xref>]. Analysis of internet search volumes for topics related to these imaging examinations may identify opportunities for improved patient outreach and education. Google search trends have been shown to correlate with both epidemiological data and public interest [<xref ref-type="bibr" rid="ref17">17</xref>-<xref ref-type="bibr" rid="ref19">19</xref>]. However, few studies have looked at general search volumes for each screening method [<xref ref-type="bibr" rid="ref20">20</xref>-<xref ref-type="bibr" rid="ref22">22</xref>], and to our knowledge no publication has documented a detailed topic-level analysis comparing all 3 types of image-based screening.</p></sec><sec id="s2" sec-type="methods"><title>Methods</title><sec id="s2-1"><title>Overview</title><p>Google Trends was used to assess long-term variation in worldwide relative search volumes for the terms &#x201C;mammography,&#x201D; &#x201C;lung cancer screening,&#x201D; and &#x201C;CT colonography&#x201D; for the period January 1, 2004 (the earliest date for which Google Trends data were retrievable) to April 1, 2023. Google was chosen, as it is the most frequently used internet search engine, consistently capturing more than 80% of the worldwide internet search market [<xref ref-type="bibr" rid="ref23">23</xref>].</p><p>Keyword tool (keywordtool.io), a commercial search engine tracking product, was used to query average volumes of monthly Google searches in English worldwide for the period May 1, 2022, to April 30, 2023 [<xref ref-type="bibr" rid="ref24">24</xref>]. Keyword tool uses the output of the Google autocomplete tool to extract the most common entries at the search prompt, which made it optimal to use for this study design [<xref ref-type="bibr" rid="ref24">24</xref>]. All questions and question-like queries entered at the Google search prompt relating to the terms &#x201C;mammography,&#x201D; &#x201C;lung cancer screening,&#x201D; and &#x201C;CT colonography&#x201D; were extracted. Two of the authors (ZDZ and BPL) used an iterative process to agree upon a list of thematic categories for queries. Search results with at least 10 monthly searches were independently assigned to the most appropriate category by the 2 graders, with disagreements resolved by consensus.</p></sec><sec id="s2-2"><title>Data Analysis</title><p>Search volumes for each screening type were plotted as normalized values (relative search volumes comprising the format of Google Trends data output), with 100 representing the highest relative search volume and 1 representing the lowest, with 0 representing a search volume of zero or insufficient search volume to calculate. Average monthly search volumes for each category were grouped by screening modality and presented in tabular format as the number of searches and as a percentage of total searches for the corresponding modality.</p></sec></sec><sec id="s3" sec-type="results"><title>Results</title><p>A plot of Google Trends data from 2004 to 2023 comparing MG, LCS, and CTC Google searches is shown in <xref ref-type="fig" rid="figure1">Figure 1</xref>. The median 20-year relative search volume was 50 (SD 13; IQR 43-57) for MG, 5 (SD 3; IQR 2-7) for LCS, and 2 (SD 1.2; IQR 1-2) for CTC. On average, the search frequency for LCS was only one-tenth of that for MG, and CTC search volume was only one&#x2013;twenty-fifth of MG search volume. Search volumes for LCS steadily increased from 2011 to 2023, while searches for MG and CTC plateaued.</p><fig position="float" id="figure1"><label>Figure 1.</label><caption><p>Relative worldwide monthly Google search volumes for imaging-based screening examinations. Graph A compares the relative average worldwide monthly search volumes for mammography, lung cancer screening, and CT colonography from January 1, 2004, to April 1, 2023. Graphs B, C, and D illustrate search volumes for the modalities taken independently. All data were obtained from Google Trends for worldwide searches in English. CT: computed tomography.</p></caption><graphic alt-version="no" mimetype="image" position="float" xlink:type="simple" xlink:href="cancer_v11i1e53328_fig01.png"/></fig><p>The relative search volumes for MG alone (<xref ref-type="fig" rid="figure1">Figure 1</xref>) across the period ranged from 30 to 100 (median 60; IQR 54-67); there was an overall decrease in relative search volume from the high in 2004 (100) to 2013 (39), followed by an overall increase from 2013 to 2019 (82), with the nadir in 2020 (30) corresponding to the onset of the COVID-19 pandemic. Relative search volumes for LCS alone ranged from 0 to 100; there was an overall decrease in relative search volumes from 2005 (90) to 2010 (0), and a subsequent uptrend after 2011, culminating in a high of 100 in 2019. Relative search volumes for CTC alone ranged from 0 to 100 with the highest volume in 2005, with a secondary peak in 2008 (47), and a plateau from 2010 to 2023 with an average of 14.</p><p>Topic analysis using Keyword tool data for the period from May 1, 2022, to April 30, 2023, showed that MG-related topics had the highest total monthly search volume (621,810 searches/month), followed by those related to LCS (23,250 searches/month), and CTC (17,690 searches/month). From these searches, a total of 751 queries classified as questions or question-like queries by the Keyword tool interface were extracted as follows: 442 for MG, 178 for LCS, and 131 for CTC. Of these, 332 had a search volume of &#x003E;10 per month. The reviewers identified 39, 14, and 11 thematic categories for MG, LCS, and CTC, respectively. The most common categories of queries for MG were nearby screening locations (60,850/253,810, 24%), general inquiries (52,460/253,810, 21%), pain associated with screening (28,970/253,810, 11%), and eligibility criteria (ages) (16,160/253,810, 6%) (<xref ref-type="table" rid="table1">Table 1</xref>). For LCS, the most frequent categories of queries were CT-specific inquiries (5380/11,150, 48%), general inquiries (1790/11,150, 16%), artificial intelligence (AI) or deep learning use in lung screening (1210/11,150, 11%), screening eligibility criteria (ages or pack-years) (1020/11,150, 9%), and nearby screening locations (750/11,150, 7%) (<xref ref-type="table" rid="table1">Table 1</xref>). The most common categories of queries related to CTC were CT-specific inquiries (1800/5590, 32%), screening procedural details (1380/5590, 25%), performance compared with colonoscopy (870/5590, 16%), and screening preparation (such as colon preparation and sedation) (720/5590, 13%) (<xref ref-type="table" rid="table1">Table 1</xref>). Examples of the most common queries for each image-based screening are presented in <xref ref-type="table" rid="table2">Table 2</xref>.</p><table-wrap id="t1" position="float"><label>Table 1.</label><caption><p>Average monthly search volumes for imaging-based screening examinations by search topic category. The table displays the average monthly Google search volumes for imaging-based screening examinations from May 1, 2022, to April 30, 2023. All data were obtained from Keyword tool (keywordtool.io) for worldwide searches performed in English. The top 10 thematic categories of search topics are listed for each modality.</p></caption><table id="table1" frame="hsides" rules="groups"><thead><tr><td align="left" valign="bottom">Imaging-based cancer screening search query categories</td><td align="left" valign="bottom">Average monthly search volume, n (%)</td></tr></thead><tbody><tr><td align="left" valign="top" colspan="2">MG<sup><xref ref-type="table-fn" rid="table1fn1">a</xref></sup> (n=253,810)</td></tr><tr><td align="left" valign="top"><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content>Nearest screening locations</td><td align="left" valign="top">60,850 (24)</td></tr><tr><td align="left" valign="top"><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content>General inquiries</td><td align="left" valign="top">52,460 (21)</td></tr><tr><td align="left" valign="top"><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content>Pain associated with screening</td><td align="left" valign="top">28,970 (11)</td></tr><tr><td align="left" valign="top"><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content>Cancer imaging characteristics</td><td align="left" valign="top">28,890 (11)</td></tr><tr><td align="left" valign="top"><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content>Screening eligibility criteria</td><td align="left" valign="top">16,160 (6)</td></tr><tr><td align="left" valign="top"><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content>Screening procedural details</td><td align="left" valign="top">11,810 (5)</td></tr><tr><td align="left" valign="top"><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content>Comparison of screening modalities (MG vs MRI<sup><xref ref-type="table-fn" rid="table1fn2">b</xref></sup>)</td><td align="left" valign="top">9120 (4)</td></tr><tr><td align="left" valign="top"><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content>General screening inquiries</td><td align="left" valign="top">8180 (3)</td></tr><tr><td align="left" valign="top"><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content>Opportunities for no-cost screening</td><td align="left" valign="top">6810 (3)</td></tr><tr><td align="left" valign="top"><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content>Breast tomosynthesis</td><td align="left" valign="top">6770 (3)</td></tr><tr><td align="left" valign="top"><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content>Other categories (combined)</td><td align="left" valign="top">23,790 (9)</td></tr><tr><td align="left" valign="top" colspan="2">LCS<sup><xref ref-type="table-fn" rid="table1fn3">c</xref></sup> (n=11,150)</td></tr><tr><td align="left" valign="top"><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content>CT<sup><xref ref-type="table-fn" rid="table1fn4">d</xref></sup>-specific inquiries</td><td align="left" valign="top">5380 (48)</td></tr><tr><td align="left" valign="top"><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content>General inquiries</td><td align="left" valign="top">1790 (16)</td></tr><tr><td align="left" valign="top"><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content>Artificial intelligence and deep learning in LCS</td><td align="left" valign="top">1210 (11)</td></tr><tr><td align="left" valign="top"><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content>Screening eligibility criteria</td><td align="left" valign="top">1020 (9)</td></tr><tr><td align="left" valign="top"><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content>Nearest screening locations</td><td align="left" valign="top">750 (7)</td></tr><tr><td align="left" valign="top"><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content>Opportunities for no-cost screening</td><td align="left" valign="top">420 (4)</td></tr><tr><td align="left" valign="top"><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content>Screening procedural details</td><td align="left" valign="top">230 (2)</td></tr><tr><td align="left" valign="top"><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content>Insurance coverage</td><td align="left" valign="top">150 (1)</td></tr><tr><td align="left" valign="top"><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content>LCS trials</td><td align="left" valign="top">90 (0.8)</td></tr><tr><td align="left" valign="top"><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content>Imaging accuracy</td><td align="left" valign="top">40 (0.4)</td></tr><tr><td align="left" valign="top"><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content>Other categories (combined)</td><td align="left" valign="top">70 (0.6)</td></tr><tr><td align="left" valign="top" colspan="2">CTC<sup><xref ref-type="table-fn" rid="table1fn5">e</xref></sup> (n=5590)</td></tr><tr><td align="left" valign="top"><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content>CT-specific inquiries</td><td align="left" valign="top">1800 (32)</td></tr><tr><td align="left" valign="top"><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content>Screening procedural details</td><td align="left" valign="top">1380 (25)</td></tr><tr><td align="left" valign="top"><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content>Imaging modality comparison (colonoscopy vs CTC)</td><td align="left" valign="top">870 (16)</td></tr><tr><td align="left" valign="top"><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content>Prescreening procedural preparation</td><td align="left" valign="top">720 (13)</td></tr><tr><td align="left" valign="top"><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content>Coding (<italic>ICD</italic><sup><xref ref-type="table-fn" rid="table1fn6">f</xref></sup>/CPT<sup><xref ref-type="table-fn" rid="table1fn7">g</xref></sup>)</td><td align="left" valign="top">230 (4)</td></tr><tr><td align="left" valign="top"><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content>Nearest screening locations</td><td align="left" valign="top">230 (4)</td></tr><tr><td align="left" valign="top"><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content>Pain associated with screening</td><td align="left" valign="top">220 (4)</td></tr><tr><td align="left" valign="top"><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content>Opportunities for no-cost screening</td><td align="left" valign="top">60 (1)</td></tr><tr><td align="left" valign="top"><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content>Diagnostic capabilities</td><td align="left" valign="top">60 (1)</td></tr><tr><td align="left" valign="top"><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content>Insurance coverage</td><td align="left" valign="top">10 (0.2)</td></tr><tr><td align="left" valign="top"><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content>Other categories (combined)</td><td align="left" valign="top">10 (0.2)</td></tr></tbody></table><table-wrap-foot><fn id="table1fn1"><p><sup>a</sup>MG: mammography.</p></fn><fn id="table1fn2"><p><sup>b</sup>MRI: magnetic resonance imaging.</p></fn><fn id="table1fn3"><p><sup>c</sup>LCS: lung cancer screening.</p></fn><fn id="table1fn4"><p><sup>d</sup>CT: computed tomography.</p></fn><fn id="table1fn5"><p><sup>e</sup>CTC: computed tomography colonography.</p></fn><fn id="table1fn6"><p><sup>f</sup><italic>ICD</italic>: <italic>International Classification of Diseases</italic>.</p></fn><fn id="table1fn7"><p><sup>g</sup>CPT: current procedural terminology.</p></fn></table-wrap-foot></table-wrap><table-wrap id="t2" position="float"><label>Table 2.</label><caption><p>The table shows examples of the 5 most common inquiries for each imaging-based cancer screening examination from May 1, 2022, to April 30, 2023. All data were obtained from Keyword tool (keywordtool.io) for worldwide searches performed in English.</p></caption><table id="table2" frame="hsides" rules="groups"><thead><tr><td align="left" valign="bottom"/><td align="left" valign="bottom">Example #1</td><td align="left" valign="bottom">Example #2</td><td align="left" valign="bottom">Example #3</td></tr></thead><tbody><tr><td align="left" valign="top" colspan="4">Mammography</td></tr><tr><td align="left" valign="top"><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content>Nearest screening locations</td><td align="left" valign="top">&#x201C;mammography near me&#x201D;</td><td align="left" valign="top">&#x201C;mammogram without referral near me&#x201D;</td><td align="left" valign="top">&#x201C;mammogram near me now&#x201D;</td></tr><tr><td align="left" valign="top"><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content>General inquires</td><td align="left" valign="top">&#x201C;what is the mammography&#x201D;</td><td align="left" valign="top">&#x201C;why mammography is important&#x201D;</td><td align="left" valign="top">&#x201C;mammography versus mammogram&#x201D;</td></tr><tr><td align="left" valign="top"><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content>Pain associated with screening</td><td align="left" valign="top">&#x201C;is mammography painful&#x201D;</td><td align="left" valign="top">&#x201C;do mammograms hurt&#x201D;</td><td align="left" valign="top">&#x201C;what does a mammogram feel like&#x201D;</td></tr><tr><td align="left" valign="top"><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content>Cancer imaging characteristics</td><td align="left" valign="top">&#x201C;mammogramof breast cancer&#x201D;</td><td align="left" valign="top">&#x201C;mammography of breast cancer images&#x201D;</td><td align="left" valign="top">&#x201C;mammography of fibroadenoma&#x201D;</td></tr><tr><td align="left" valign="top"><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content>Screening eligibility criteria</td><td align="left" valign="top">&#x201C;mammography at what age&#x201D;</td><td align="left" valign="top">&#x201C;when should mammograms be done&#x201D;</td><td align="left" valign="top">&#x201C;mammography before 40&#x201D;</td></tr><tr><td align="left" valign="top" colspan="4">Lung cancer screening</td></tr><tr><td align="left" valign="top"><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content>CT<sup><xref ref-type="table-fn" rid="table2fn1">a</xref></sup>-specific inquiries</td><td align="left" valign="top">&#x201C;lung cancer screening with low dose ct&#x201D;</td><td align="left" valign="top">&#x201C;low dose lung cancer screening&#x201D;</td><td align="left" valign="top">&#x201C;lung cancer detection using ct scan images&#x201D;</td></tr><tr><td align="left" valign="top"><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content>General inquires</td><td align="left" valign="top">&#x201C;lung cancer screening tests&#x201D;</td><td align="left" valign="top">&#x201C;what is a lung cancer screening&#x201D;</td><td align="left" valign="top">&#x201C;lung cancer screening for smokers&#x201D;</td></tr><tr><td align="left" valign="top"><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content>Artificial intelligence and deep learning in LCS<sup><xref ref-type="table-fn" rid="table2fn2">b</xref></sup></td><td align="left" valign="top">&#x201C;lung cancer detection using image processing&#x201D;</td><td align="left" valign="top">&#x201C;lung cancer detection using deep learning&#x201D;</td><td align="left" valign="top">&#x201C;lung cancer detection using machine learning&#x201D;</td></tr><tr><td align="left" valign="top"><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content>Screening eligibility criteria</td><td align="left" valign="top">&#x201C;lung cancer screening ages&#x201D;</td><td align="left" valign="top">&#x201C;criteria for lung cancer screening&#x201D;</td><td align="left" valign="top">&#x201C;who should be screened for lung cancer&#x201D;</td></tr><tr><td align="left" valign="top"><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content>Nearest screening locations</td><td align="left" valign="top">&#x201C;lung cancer screening near me&#x201D;</td><td align="left" valign="top">&#x201C;mobile lung cancer screening near me&#x201D;</td><td align="left" valign="top">&#x201C;private lung cancer screening near me&#x201D;</td></tr><tr><td align="left" valign="top" colspan="4">CT colonography</td></tr><tr><td align="left" valign="top"><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content>CT-specific inquiries</td><td align="left" valign="top">&#x201C;what is a ct colonography&#x201D;</td><td align="left" valign="top">&#x201C;ct colonography with contrast&#x201D;</td><td align="left" valign="top">&#x201C;ct colonography without contrast&#x201D;</td></tr><tr><td align="left" valign="top"><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content>Screening procedural details</td><td align="left" valign="top">&#x201C;ct colonography procedure&#x201D;</td><td align="left" valign="top">&#x201C;does ct colonography use contrast&#x201D;</td><td align="left" valign="top">&#x201C;how is ct colonography performed&#x201D;</td></tr><tr><td align="left" valign="top"><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content>Imaging modality comparison (colonoscopy versus CTC<sup><xref ref-type="table-fn" rid="table2fn3">c</xref></sup>)</td><td align="left" valign="top">&#x201C;ct colonography versus colonoscopy cost&#x201D;</td><td align="left" valign="top">&#x201C;ct colonography versus colonoscopy sensitivity&#x201D;</td><td align="left" valign="top">&#x201C;is ct colonography as good as colonoscopy&#x201D;</td></tr><tr><td align="left" valign="top"><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content>Prescreening procedural preparation</td><td align="left" valign="top">&#x201C;what is the prep for a ct colonography&#x201D;</td><td align="left" valign="top">&#x201C;what is the prep for a ct colonography nhs&#x201D;</td><td align="left" valign="top">&#x2014;<sup><xref ref-type="table-fn" rid="table2fn4">d</xref></sup></td></tr><tr><td align="left" valign="top"><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content>Coding (<italic>ICD</italic><sup><xref ref-type="table-fn" rid="table2fn5">e</xref></sup>/CPT<sup><xref ref-type="table-fn" rid="table2fn6">f</xref></sup>)</td><td align="left" valign="top">&#x201C;ct colonography cpt code&#x201D;</td><td align="left" valign="top">&#x201C;ct colonography cpt&#x201D;</td><td align="left" valign="top">&#x2014;</td></tr></tbody></table><table-wrap-foot><fn id="table2fn1"><p><sup>a</sup>CT: computed tomography.</p></fn><fn id="table2fn2"><p><sup>b</sup>LCS: lung cancer screening.</p></fn><fn id="table2fn3"><p><sup>c</sup>CTC: computed tomography colonography.</p></fn><fn id="table2fn4"><p><sup>d</sup>Not available.</p></fn><fn id="table2fn5"><p><sup>e</sup><italic>ICD</italic>: <italic>International Classification of Diseases</italic>.</p></fn><fn id="table2fn6"><p><sup>f</sup>CPT: current procedural terminology.</p></fn></table-wrap-foot></table-wrap></sec><sec id="s4" sec-type="discussion"><title>Discussion</title><sec id="s4-1"><title>Principal Findings</title><sec id="s4-1-1"><title>Overview</title><p>Our study revealed much higher Google search volumes for MG topics over the past 2 decades than for LCS and CTC. The average search frequency for LCS was only approximately one-tenth of that for MG, and CTC search volume was only one&#x2013;twenty-fifth of MG search volume. LCS average search volumes increased from 2011 to 2023, while searches for MG and CTC plateaued. MG-related topics had the highest total monthly search volume, followed by those related to LCS and CTC. Frequently searched topics varied across modalities and included nearby screening locations, procedural details or associated pain, and eligibility criteria.</p><p>MG consistently exhibited higher levels of search interest compared with LCS or CTC, possibly reflecting the longer history of MG and various longstanding initiatives focused on breast screening and women&#x2019;s health [<xref ref-type="bibr" rid="ref25">25</xref>,<xref ref-type="bibr" rid="ref26">26</xref>]. Despite the higher absolute mortality for lung cancer than for breast cancer globally, search volumes for topics related to LCS have remained much lower than those for MG, although LCS search volumes have experienced an uptrend since 2011, when the National Lung Screening Trial was published [<xref ref-type="bibr" rid="ref3">3</xref>]. MG was first established in 1913 and fully adopted in the 1970s [<xref ref-type="bibr" rid="ref25">25</xref>], in contrast to low-dose CT for LCS, which gained widespread recognition in 2011. The early peak of interest in LCS in the 2004&#x2010;2006 period coincides with attention generated by early CT LCS programs, followed by a decline in interest until 2011 [<xref ref-type="bibr" rid="ref27">27</xref>,<xref ref-type="bibr" rid="ref28">28</xref>]. The relative search volumes for CTC have been persistently low over the last 2 decades, especially compared with MG (2%). While CTC is recognized by the national medical societies and formal guidelines of several countries as a viable screening option [<xref ref-type="bibr" rid="ref29">29</xref>-<xref ref-type="bibr" rid="ref31">31</xref>], other organizations have raised concerns regarding the strength of evidence supporting CTC or cost-effectiveness compared with colonoscopy [<xref ref-type="bibr" rid="ref32">32</xref>,<xref ref-type="bibr" rid="ref33">33</xref>]. The low search volumes might reflect a lack of awareness or desire for this screening option among the public.</p><p>Our topic analysis of recent volumes for queries related to image-based screening techniques showed both similarities and differences across imaging modalities. For example, in the case of MG, a substantial portion of searches (60,850/253,810, 24%) involved the nearest screening center, a topic with substantial although lower percentages of search volumes for LCS (750/11,150, 7%) and CTC (230/5590, 4%), highlighting a possible target of increased or more effective publicity. A relatively high volume of searches related to procedural aspects of CTC (1380/5590, 25%) may suggest a relative unfamiliarity with details of this specific imaging modality. A common topic of searches was potential procedural discomfort or pain in MG (28,970/253,810, 11%), with a lower percentage for CTC (220/5590, 1%), suggesting an opportunity for providers to better address procedural comfort that might otherwise decrease screening uptake. Cost or insurance coverage for screening was in the top 10 most-searched topics for all 3 screening modalities but comprised a minority of searches in terms of percentage; although cost and coverage pose concerns for some individuals, it is notable that several other topics, such as the nearest screening locations, procedural pain, and eligibility criteria, had on average 2- to 3-fold higher search volumes. AI and deep learning were common search topics for LCS (1210/11,150, 11%) but were not common queries for MG or CTC; this is somewhat surprising, as AI in the form of computer-aided detection is commonly used in MG.</p></sec><sec id="s4-1-2"><title>Comparison to Prior Work</title><p>Previous research has examined internet search trends for cancer screening examinations. Snyder et al [<xref ref-type="bibr" rid="ref20">20</xref>] examined Google search volume trends for cancer screening terms during the first stages of the COVID-19 pandemic, finding a temporary decline in searches for terms related to MG, LCS, colonoscopy, and pap smear. Rosenkrantz and Prabhu [<xref ref-type="bibr" rid="ref22">22</xref>] performed a Google Trends analysis of the relative frequency of Google searches for MG, LCS, CTC, and prostate magnetic resonance imaging from 2004 to 2014, finding a slight progressive decline over the decade in searches for MG, a decrease from 2004 to 2010 in searches for LCS, followed by a persistent increase beginning in 2011, and an overall decade-long decline in searches for CTC; these findings are consistent with our analysis, although we show that searches for LCS continued to rise from 2014 to 2023 and that searches for MG and CTC have continued to plateau. Our analysis also has the advantage of comparing both the relative and absolute volumes of searches across modalities (MG, LCS, and CTC) instead of relying solely on relative search volumes, showing that searches related to MG greatly exceeded those related to LCS and CTC.</p><p>A variety of other methods have been used to assess public interest in and knowledge of cancer screening, including interviews, focus group discussions, questionnaires, and news coverage analysis [<xref ref-type="bibr" rid="ref10">10</xref>,<xref ref-type="bibr" rid="ref34">34</xref>,<xref ref-type="bibr" rid="ref35">35</xref>]. Raju et al&#x2019;s [<xref ref-type="bibr" rid="ref34">34</xref>] survey of LCS-eligible individuals who chose not to participate in screening found that 19% of individuals had concerns about the distance to the screening site, and 14% of individuals had concerns about insurance coverage, recalling some of the frequent search topics for LCS in our study. In a Google News analysis of news coverage of MG from 2006 to 2015 [<xref ref-type="bibr" rid="ref21">21</xref>], the most frequently covered topics included screening MG controversies (29%), new breast imaging technology (23%), imaging of dense breasts (11%), and public screening initiatives (11%), topics that were not among the most common MG searches in our study.</p></sec><sec id="s4-1-3"><title>Strengths and Limitations</title><p>To our knowledge, our study is the first to use internet search engine data to gauge both general and topic-level public interest across imaging-based screening modalities by providing both relative search frequencies and estimates of absolute search volumes. We examined 2 decades of Google search volumes across 3 key imaging-based cancer screening examinations and documented the most common themes of recent related search queries.</p><p>Our study had several limitations. First, there are limitations inherent in any method of search volume estimation. Google Trends reports search data in relative terms and may report a value of 0 when search frequencies are low. For topic analysis, we captured data representing a snapshot of queries over a year, while queries may change over time. Search volumes were also estimated through a proprietary tool that uses Google autocomplete as a proxy for search volumes, as actual absolute search volumes are not available from Google Trends. However, our goal was not to measure exact search volumes but rather to analyze and compare trends across modalities and to discern the topics of the most frequent searches. Second, the analysis of thematic categories is intrinsically subjective; we attempted to mitigate this by using 2 observers, with final decisions rendered by consensus. Third, we analyzed worldwide Google searches in English and did not perform a country or region-specific analysis; while such comparative analyses are potentially of interest because of differences in screening guidelines and behavior across countries, our main objectives were to provide a general and comprehensive analysis of search interest across modalities and to determine the main topics of search queries. Future studies may incorporate comparisons of search queries across countries. Finally, internet search volumes may not directly translate to individual concerns, real-world behaviors, or screening uptake; however, individuals frequently turn to the internet as a source of medical information [<xref ref-type="bibr" rid="ref16">16</xref>], and internet searches have often been used as a proxy of public interest in a wide variety of health-related topics [<xref ref-type="bibr" rid="ref17">17</xref>-<xref ref-type="bibr" rid="ref20">20</xref>,<xref ref-type="bibr" rid="ref22">22</xref>].</p></sec></sec><sec id="s4-2"><title>Conclusions</title><p>In conclusion, MG has generated consistently higher Google search volumes over the past 2 decades than LCS and CTC, but search interest in LCS has been on an upward trend since 2011. Frequently searched topics varied across modalities and included nearby screening locations, procedural details or associated pain, and eligibility criteria. These search trends might inform the development of communication strategies related to screening and aid in addressing frequently asked questions from the public.</p></sec></sec></body><back><ack><p>Generative artificial intelligence was not used for any portion of the study or for any portion of manuscript writing.</p></ack><notes><sec><title>Data Availability</title><p>The datasets generated or analyzed during this study are not publicly available due to the proprietary nature of one of the search analysis tools used but are available from the corresponding author on reasonable request.</p></sec></notes><fn-group><fn fn-type="con"><p>ZDZ and BPL contributed to data curation, formal analysis, and methodology. ZDZ, IOC, RAG, EMJ, MRM, PJM, SKS, JTS, and BPL were involved in conceptualization, drafting the original manuscript, and reviewing and editing the final version.</p></fn><fn fn-type="conflict"><p>None declared.</p></fn></fn-group><glossary><title>Abbreviations:</title><def-list><def-item><term id="abb1">AI</term><def><p>artificial intelligence</p></def></def-item><def-item><term id="abb2">CT</term><def><p>computed tomography</p></def></def-item><def-item><term id="abb3">CTC</term><def><p>computed tomography colonography</p></def></def-item><def-item><term id="abb4">LCS</term><def><p>lung cancer screening</p></def></def-item><def-item><term id="abb5">MG</term><def><p>mammography</p></def></def-item></def-list></glossary><ref-list><title>References</title><ref id="ref1"><label>1</label><nlm-citation citation-type="web"><article-title>Global cancer burden growing, amidst mounting need for services</article-title><source>World Health Organization</source><access-date>2024-01-07</access-date><comment><ext-link ext-link-type="uri" xlink:href="https://www.who.int/news/item/01-02-2024-global-cancer-burden-growing--amidst-mounting-need-for-services">https://www.who.int/news/item/01-02-2024-global-cancer-burden-growing--amidst-mounting-need-for-services</ext-link></comment></nlm-citation></ref><ref id="ref2"><label>2</label><nlm-citation citation-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Myers</surname><given-names>ER</given-names> </name><name name-style="western"><surname>Moorman</surname><given-names>P</given-names> </name><name name-style="western"><surname>Gierisch</surname><given-names>JM</given-names> </name><etal/></person-group><article-title>Benefits and harms of breast cancer screening: a systematic review</article-title><source>JAMA</source><year>2015</year><month>10</month><day>20</day><volume>314</volume><issue>15</issue><fpage>1615</fpage><lpage>1634</lpage><pub-id pub-id-type="doi">10.1001/jama.2015.13183</pub-id><pub-id pub-id-type="medline">26501537</pub-id></nlm-citation></ref><ref id="ref3"><label>3</label><nlm-citation citation-type="journal"><person-group person-group-type="author"><collab>National Lung Screening Trial Research Team</collab><name name-style="western"><surname>Aberle</surname><given-names>DR</given-names> </name><name name-style="western"><surname>Adams</surname><given-names>AM</given-names> </name><etal/></person-group><article-title>Reduced lung-cancer mortality with low-dose computed tomographic screening</article-title><source>N Engl J Med</source><year>2011</year><month>08</month><day>4</day><volume>365</volume><issue>5</issue><fpage>395</fpage><lpage>409</lpage><pub-id pub-id-type="doi">10.1056/NEJMoa1102873</pub-id><pub-id pub-id-type="medline">21714641</pub-id></nlm-citation></ref><ref id="ref4"><label>4</label><nlm-citation citation-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>de Koning</surname><given-names>HJ</given-names> </name><name name-style="western"><surname>van der Aalst</surname><given-names>CM</given-names> </name><name name-style="western"><surname>de Jong</surname><given-names>PA</given-names> </name><etal/></person-group><article-title>Reduced lung-cancer mortality with volume CT screening in a randomized trial</article-title><source>N Engl J Med</source><year>2020</year><month>02</month><day>6</day><volume>382</volume><issue>6</issue><fpage>503</fpage><lpage>513</lpage><pub-id pub-id-type="doi">10.1056/NEJMoa1911793</pub-id><pub-id pub-id-type="medline">31995683</pub-id></nlm-citation></ref><ref id="ref5"><label>5</label><nlm-citation citation-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Nystr&#x00F6;m</surname><given-names>L</given-names> </name><name name-style="western"><surname>Bjurstam</surname><given-names>N</given-names> </name><name name-style="western"><surname>Jonsson</surname><given-names>H</given-names> </name><name name-style="western"><surname>Zackrisson</surname><given-names>S</given-names> </name><name name-style="western"><surname>Frisell</surname><given-names>J</given-names> </name></person-group><article-title>Reduced breast cancer mortality after 20+ years of follow-up in the Swedish randomized controlled mammography trials in Malm&#x00F6;, Stockholm, and G&#x00F6;teborg</article-title><source>J Med Screen</source><year>2017</year><month>03</month><volume>24</volume><issue>1</issue><fpage>34</fpage><lpage>42</lpage><pub-id pub-id-type="doi">10.1177/0969141316648987</pub-id><pub-id pub-id-type="medline">27306511</pub-id></nlm-citation></ref><ref id="ref6"><label>6</label><nlm-citation citation-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Field</surname><given-names>JK</given-names> </name><name name-style="western"><surname>Vulkan</surname><given-names>D</given-names> </name><name name-style="western"><surname>Davies</surname><given-names>MPA</given-names> </name><etal/></person-group><article-title>Lung cancer mortality reduction by LDCT screening: UKLS randomised trial results and international meta-analysis</article-title><source>Lancet Reg Health Eur</source><year>2021</year><month>11</month><volume>10</volume><fpage>100179</fpage><pub-id pub-id-type="doi">10.1016/j.lanepe.2021.100179</pub-id><pub-id pub-id-type="medline">34806061</pub-id></nlm-citation></ref><ref id="ref7"><label>7</label><nlm-citation citation-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>McInnerney</surname><given-names>D</given-names> </name><name name-style="western"><surname>Simmonds</surname><given-names>I</given-names> </name><name name-style="western"><surname>Hancock</surname><given-names>N</given-names> </name><etal/></person-group><article-title>Yorkshire Lung Screening Trial (YLST) pathway navigation study: a protocol for a nested randomised controlled trial to evaluate the effect of a pathway navigation intervention on lung cancer screening uptake</article-title><source>BMJ Open</source><year>2024</year><month>07</month><day>9</day><volume>14</volume><issue>7</issue><fpage>e084577</fpage><pub-id pub-id-type="doi">10.1136/bmjopen-2024-084577</pub-id><pub-id pub-id-type="medline">38986555</pub-id></nlm-citation></ref><ref id="ref8"><label>8</label><nlm-citation citation-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Tao</surname><given-names>W</given-names> </name><name name-style="western"><surname>Yu</surname><given-names>X</given-names> </name><name name-style="western"><surname>Shao</surname><given-names>J</given-names> </name><name name-style="western"><surname>Li</surname><given-names>R</given-names> </name><name name-style="western"><surname>Li</surname><given-names>W</given-names> </name></person-group><article-title>Telemedicine-enhanced lung cancer screening using mobile computed tomography unit with remote artificial intelligence assistance in underserved communities: initial results of a population cohort study in Western China</article-title><source>Telemed J E Health</source><year>2024</year><month>06</month><volume>30</volume><issue>6</issue><fpage>e1695</fpage><lpage>e1704</lpage><pub-id pub-id-type="doi">10.1089/tmj.2023.0648</pub-id><pub-id pub-id-type="medline">38436233</pub-id></nlm-citation></ref><ref id="ref9"><label>9</label><nlm-citation citation-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>de-Torres</surname><given-names>JP</given-names> </name><name name-style="western"><surname>Alcaide</surname><given-names>AB</given-names> </name><name name-style="western"><surname>Campo</surname><given-names>A</given-names> </name><etal/></person-group><article-title>Lung cancer screening in people with COPD: the Pamplona-IELCAP experience</article-title><source>Arch Bronconeumol</source><year>2024</year><month>02</month><volume>60</volume><issue>2</issue><fpage>95</fpage><lpage>100</lpage><pub-id pub-id-type="doi">10.1016/j.arbres.2023.12.012</pub-id></nlm-citation></ref><ref id="ref10"><label>10</label><nlm-citation citation-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ren</surname><given-names>W</given-names> </name><name name-style="western"><surname>Chen</surname><given-names>M</given-names> </name><name name-style="western"><surname>Qiao</surname><given-names>Y</given-names> </name><name name-style="western"><surname>Zhao</surname><given-names>F</given-names> </name></person-group><article-title>Global guidelines for breast cancer screening: a systematic review</article-title><source>Breast</source><year>2022</year><month>08</month><volume>64</volume><fpage>85</fpage><lpage>99</lpage><pub-id pub-id-type="doi">10.1016/j.breast.2022.04.003</pub-id><pub-id pub-id-type="medline">35636342</pub-id></nlm-citation></ref><ref id="ref11"><label>11</label><nlm-citation citation-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Caruso</surname><given-names>D</given-names> </name><name name-style="western"><surname>Polici</surname><given-names>M</given-names> </name><name name-style="western"><surname>Bellini</surname><given-names>D</given-names> </name><name name-style="western"><surname>Laghi</surname><given-names>A</given-names> </name></person-group><article-title>ESR essentials: imaging in colorectal cancer-practice recommendations by ESGAR</article-title><source>Eur Radiol</source><year>2024</year><month>09</month><volume>34</volume><issue>9</issue><fpage>5903</fpage><lpage>5910</lpage><pub-id pub-id-type="doi">10.1007/s00330-024-10645-3</pub-id><pub-id pub-id-type="medline">38418627</pub-id></nlm-citation></ref><ref id="ref12"><label>12</label><nlm-citation citation-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Smyth</surname><given-names>AE</given-names> </name><name name-style="western"><surname>Healy</surname><given-names>CF</given-names> </name><name name-style="western"><surname>Aherne</surname><given-names>EA</given-names> </name><name name-style="western"><surname>MacMathuna</surname><given-names>P</given-names> </name><name name-style="western"><surname>Morrin</surname><given-names>MM</given-names> </name><name name-style="western"><surname>Fenlon</surname><given-names>HM</given-names> </name></person-group><article-title>National survey of CT colonography practice in Ireland</article-title><source>Ir Med J</source><year>2016</year><month>06</month><day>10</day><volume>109</volume><issue>6</issue><fpage>419</fpage><pub-id pub-id-type="medline">27814436</pub-id></nlm-citation></ref><ref id="ref13"><label>13</label><nlm-citation citation-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lam</surname><given-names>S</given-names> </name><name name-style="western"><surname>Bai</surname><given-names>C</given-names> </name><name name-style="western"><surname>Baldwin</surname><given-names>DR</given-names> </name><etal/></person-group><article-title>Current and future perspectives on computed tomography screening for lung cancer: a roadmap from 2023 to 2027 from the international association for the study of lung cancer</article-title><source>J Thorac Oncol</source><year>2024</year><month>01</month><volume>19</volume><issue>1</issue><fpage>36</fpage><lpage>51</lpage><pub-id pub-id-type="doi">10.1016/j.jtho.2023.07.019</pub-id><pub-id pub-id-type="medline">37487906</pub-id></nlm-citation></ref><ref id="ref14"><label>14</label><nlm-citation citation-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Leiter</surname><given-names>A</given-names> </name><name name-style="western"><surname>Veluswamy</surname><given-names>RR</given-names> </name><name name-style="western"><surname>Wisnivesky</surname><given-names>JP</given-names> </name></person-group><article-title>The global burden of lung cancer: current status and future trends</article-title><source>Nat Rev Clin Oncol</source><year>2023</year><month>09</month><volume>20</volume><issue>9</issue><fpage>624</fpage><lpage>639</lpage><pub-id pub-id-type="doi">10.1038/s41571-023-00798-3</pub-id><pub-id pub-id-type="medline">37479810</pub-id></nlm-citation></ref><ref id="ref15"><label>15</label><nlm-citation citation-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Tavakoli</surname><given-names>B</given-names> </name><name name-style="western"><surname>Feizi</surname><given-names>A</given-names> </name><name name-style="western"><surname>Zamani-Alavijeh</surname><given-names>F</given-names> </name><name name-style="western"><surname>Shahnazi</surname><given-names>H</given-names> </name></person-group><article-title>Factors influencing breast cancer screening practices among women worldwide: a systematic review of observational and qualitative studies</article-title><source>BMC Womens Health</source><year>2024</year><month>04</month><day>27</day><volume>24</volume><issue>1</issue><fpage>268</fpage><pub-id pub-id-type="doi">10.1186/s12905-024-03096-x</pub-id><pub-id pub-id-type="medline">38678224</pub-id></nlm-citation></ref><ref id="ref16"><label>16</label><nlm-citation citation-type="web"><article-title>Health online 2013</article-title><source>Pew Research Center</source><year>2013</year><access-date>2023-07-05</access-date><comment><ext-link ext-link-type="uri" xlink:href="https://www.pewresearch.org/internet/2013/01/15/health-online-2013">https://www.pewresearch.org/internet/2013/01/15/health-online-2013</ext-link></comment></nlm-citation></ref><ref id="ref17"><label>17</label><nlm-citation citation-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Mavragani</surname><given-names>A</given-names> </name></person-group><article-title>Infodemiology and infoveillance: scoping review</article-title><source>J Med Internet Res</source><year>2020</year><month>04</month><day>28</day><volume>22</volume><issue>4</issue><fpage>e16206</fpage><pub-id pub-id-type="doi">10.2196/16206</pub-id><pub-id pub-id-type="medline">32310818</pub-id></nlm-citation></ref><ref id="ref18"><label>18</label><nlm-citation citation-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Watad</surname><given-names>A</given-names> </name><name name-style="western"><surname>Watad</surname><given-names>S</given-names> </name><name name-style="western"><surname>Mahroum</surname><given-names>N</given-names> </name><etal/></person-group><article-title>Forecasting the West Nile virus in the United States: an extensive novel data streams-based time series analysis and structural equation modeling of related digital searching behavior</article-title><source>JMIR Public Health Surveill</source><year>2019</year><month>02</month><day>28</day><volume>5</volume><issue>1</issue><fpage>e9176</fpage><pub-id pub-id-type="doi">10.2196/publichealth.9176</pub-id><pub-id pub-id-type="medline">30601755</pub-id></nlm-citation></ref><ref id="ref19"><label>19</label><nlm-citation citation-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Gianfredi</surname><given-names>V</given-names> </name><name name-style="western"><surname>Bragazzi</surname><given-names>NL</given-names> </name><name name-style="western"><surname>Mahamid</surname><given-names>M</given-names> </name><etal/></person-group><article-title>Monitoring public interest toward pertussis outbreaks: an extensive Google Trends-based analysis</article-title><source>Public Health</source><year>2018</year><month>12</month><volume>165</volume><fpage>9</fpage><lpage>15</lpage><pub-id pub-id-type="doi">10.1016/j.puhe.2018.09.001</pub-id><pub-id pub-id-type="medline">30342281</pub-id></nlm-citation></ref><ref id="ref20"><label>20</label><nlm-citation citation-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Snyder</surname><given-names>A</given-names> </name><name name-style="western"><surname>Jang</surname><given-names>S</given-names> </name><name name-style="western"><surname>Nazari</surname><given-names>IS</given-names> </name><etal/></person-group><article-title>Google search volume trends for cancer screening terms during the COVID-19 pandemic</article-title><source>J Med Screen</source><year>2021</year><month>06</month><volume>28</volume><issue>2</issue><fpage>210</fpage><lpage>212</lpage><pub-id pub-id-type="doi">10.1177/0969141321999426</pub-id><pub-id pub-id-type="medline">33663240</pub-id></nlm-citation></ref><ref id="ref21"><label>21</label><nlm-citation citation-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Young Lin</surname><given-names>LL</given-names> </name><name name-style="western"><surname>Rosenkrantz</surname><given-names>AB</given-names> </name></person-group><article-title>The U.S. online news coverage of mammography based on a Google News search</article-title><source>Acad Radiol</source><year>2017</year><month>12</month><volume>24</volume><issue>12</issue><fpage>1612</fpage><lpage>1615</lpage><pub-id pub-id-type="doi">10.1016/j.acra.2017.05.011</pub-id><pub-id pub-id-type="medline">28693758</pub-id></nlm-citation></ref><ref id="ref22"><label>22</label><nlm-citation citation-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Rosenkrantz</surname><given-names>AB</given-names> </name><name name-style="western"><surname>Prabhu</surname><given-names>V</given-names> </name></person-group><article-title>Public interest in imaging-based cancer screening examinations in the United States: analysis using a web-based search tool</article-title><source>AJR Am J Roentgenol</source><year>2016</year><month>01</month><volume>206</volume><issue>1</issue><fpage>113</fpage><lpage>118</lpage><pub-id pub-id-type="doi">10.2214/AJR.15.14840</pub-id><pub-id pub-id-type="medline">26700342</pub-id></nlm-citation></ref><ref id="ref23"><label>23</label><nlm-citation citation-type="web"><person-group person-group-type="author"><name name-style="western"><surname>Bianchi</surname><given-names>T</given-names> </name></person-group><article-title>Market share of leading desktop search engines worldwide from january 2015 to january 2025</article-title><source>Statista</source><access-date>2024-04-22</access-date><comment><ext-link ext-link-type="uri" xlink:href="https://www.statista.com/statistics/216573/worldwide-market-share-of-search-engines">https://www.statista.com/statistics/216573/worldwide-market-share-of-search-engines</ext-link></comment></nlm-citation></ref><ref id="ref24"><label>24</label><nlm-citation citation-type="web"><article-title>Find great keywords using google autocomplete</article-title><source>Keyword Tool</source><access-date>2023-05-05</access-date><comment><ext-link ext-link-type="uri" xlink:href="https://keywordtool.io">https://keywordtool.io</ext-link></comment></nlm-citation></ref><ref id="ref25"><label>25</label><nlm-citation citation-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Gold</surname><given-names>RH</given-names> </name><name name-style="western"><surname>Bassett</surname><given-names>LW</given-names> </name><name name-style="western"><surname>Widoff</surname><given-names>BE</given-names> </name></person-group><article-title>Highlights from the history of mammography</article-title><source>Radiographics</source><year>1990</year><month>11</month><volume>10</volume><issue>6</issue><fpage>1111</fpage><lpage>1131</lpage><pub-id pub-id-type="doi">10.1148/radiographics.10.6.2259767</pub-id><pub-id pub-id-type="medline">2259767</pub-id></nlm-citation></ref><ref id="ref26"><label>26</label><nlm-citation citation-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>O&#x2019;Mahony</surname><given-names>M</given-names> </name><name name-style="western"><surname>Comber</surname><given-names>H</given-names> </name><name name-style="western"><surname>Fitzgerald</surname><given-names>T</given-names> </name><etal/></person-group><article-title>Interventions for raising breast cancer awareness in women</article-title><source>Cochrane Database Syst Rev</source><year>2017</year><month>02</month><day>10</day><volume>2</volume><issue>2</issue><fpage>CD011396</fpage><pub-id pub-id-type="doi">10.1002/14651858.CD011396.pub2</pub-id><pub-id pub-id-type="medline">28185268</pub-id></nlm-citation></ref><ref id="ref27"><label>27</label><nlm-citation citation-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Nawa</surname><given-names>T</given-names> </name><name name-style="western"><surname>Nakagawa</surname><given-names>T</given-names> </name><name name-style="western"><surname>Kusano</surname><given-names>S</given-names> </name><name name-style="western"><surname>Kawasaki</surname><given-names>Y</given-names> </name><name name-style="western"><surname>Sugawara</surname><given-names>Y</given-names> </name><name name-style="western"><surname>Nakata</surname><given-names>H</given-names> </name></person-group><article-title>Lung cancer screening using low-dose spiral CT: results of baseline and 1-year follow-up studies</article-title><source>Chest</source><year>2002</year><month>07</month><volume>122</volume><issue>1</issue><fpage>15</fpage><lpage>20</lpage><pub-id pub-id-type="doi">10.1378/chest.122.1.15</pub-id><pub-id pub-id-type="medline">12114333</pub-id></nlm-citation></ref><ref id="ref28"><label>28</label><nlm-citation citation-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wilson</surname><given-names>DO</given-names> </name><name name-style="western"><surname>Weissfeld</surname><given-names>JL</given-names> </name><name name-style="western"><surname>Fuhrman</surname><given-names>CR</given-names> </name><etal/></person-group><article-title>The Pittsburgh Lung Screening Study (PLuSS): outcomes within 3 years of a first computed tomography scan</article-title><source>Am J Respir Crit Care Med</source><year>2008</year><month>11</month><day>1</day><volume>178</volume><issue>9</issue><fpage>956</fpage><lpage>961</lpage><pub-id pub-id-type="doi">10.1164/rccm.200802-336OC</pub-id><pub-id pub-id-type="medline">18635890</pub-id></nlm-citation></ref><ref id="ref29"><label>29</label><nlm-citation citation-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wolf</surname><given-names>AMD</given-names> </name><name name-style="western"><surname>Fontham</surname><given-names>ETH</given-names> </name><name name-style="western"><surname>Church</surname><given-names>TR</given-names> </name><etal/></person-group><article-title>Colorectal cancer screening for average-risk adults: 2018 guideline update from the American Cancer Society</article-title><source>CA Cancer J Clin</source><year>2018</year><month>07</month><volume>68</volume><issue>4</issue><fpage>250</fpage><lpage>281</lpage><pub-id pub-id-type="doi">10.3322/caac.21457</pub-id><pub-id pub-id-type="medline">29846947</pub-id></nlm-citation></ref><ref id="ref30"><label>30</label><nlm-citation citation-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Spada</surname><given-names>C</given-names> </name><name name-style="western"><surname>Hassan</surname><given-names>C</given-names> </name><name name-style="western"><surname>Bellini</surname><given-names>D</given-names> </name><etal/></person-group><article-title>Imaging alternatives to colonoscopy: CT colonography and colon capsule. European Society of Gastrointestinal Endoscopy (ESGE) and European Society of Gastrointestinal and Abdominal Radiology (ESGAR) guideline - update 2020</article-title><source>Eur Radiol</source><year>2021</year><month>05</month><volume>31</volume><issue>5</issue><fpage>2967</fpage><lpage>2982</lpage><pub-id pub-id-type="doi">10.1007/s00330-020-07413-4</pub-id><pub-id pub-id-type="medline">33104846</pub-id></nlm-citation></ref><ref id="ref31"><label>31</label><nlm-citation citation-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Moreno</surname><given-names>C</given-names> </name><name name-style="western"><surname>Kim</surname><given-names>DH</given-names> </name><name name-style="western"><surname>Bartel</surname><given-names>TB</given-names> </name><etal/></person-group><article-title>ACR appropriateness criteria &#x00AE; colorectal cancer screening</article-title><source>J Am Coll Radiol</source><year>2018</year><month>05</month><volume>15</volume><issue>5</issue><fpage>S56</fpage><lpage>S68</lpage><pub-id pub-id-type="doi">10.1016/j.jacr.2018.03.014</pub-id></nlm-citation></ref><ref id="ref32"><label>32</label><nlm-citation citation-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lin</surname><given-names>JS</given-names> </name><name name-style="western"><surname>Perdue</surname><given-names>LA</given-names> </name><name name-style="western"><surname>Henrikson</surname><given-names>NB</given-names> </name><name name-style="western"><surname>Bean</surname><given-names>SI</given-names> </name><name name-style="western"><surname>Blasi</surname><given-names>PR</given-names> </name></person-group><article-title>Screening for colorectal cancer: updated evidence report and systematic review for the US preventive services task force</article-title><source>JAMA</source><year>2021</year><month>05</month><day>18</day><volume>325</volume><issue>19</issue><fpage>1978</fpage><lpage>1998</lpage><pub-id pub-id-type="doi">10.1001/jama.2021.4417</pub-id><pub-id pub-id-type="medline">34003220</pub-id></nlm-citation></ref><ref id="ref33"><label>33</label><nlm-citation citation-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kriza</surname><given-names>C</given-names> </name><name name-style="western"><surname>Emmert</surname><given-names>M</given-names> </name><name name-style="western"><surname>Wahlster</surname><given-names>P</given-names> </name><name name-style="western"><surname>Niederl&#x00E4;nder</surname><given-names>C</given-names> </name><name name-style="western"><surname>Kolominsky-Rabas</surname><given-names>P</given-names> </name></person-group><article-title>An international review of the main cost-effectiveness drivers of virtual colonography versus conventional colonoscopy for colorectal cancer screening: is the tide changing due to adherence?</article-title><source>Eur J Radiol</source><year>2013</year><month>11</month><volume>82</volume><issue>11</issue><fpage>e629</fpage><lpage>36</lpage><pub-id pub-id-type="doi">10.1016/j.ejrad.2013.07.019</pub-id><pub-id pub-id-type="medline">23938237</pub-id></nlm-citation></ref><ref id="ref34"><label>34</label><nlm-citation citation-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Raju</surname><given-names>S</given-names> </name><name name-style="western"><surname>Khawaja</surname><given-names>A</given-names> </name><name name-style="western"><surname>Han</surname><given-names>X</given-names> </name><name name-style="western"><surname>Wang</surname><given-names>X</given-names> </name><name name-style="western"><surname>Mazzone</surname><given-names>PJ</given-names> </name></person-group><article-title>Lung cancer screening: characteristics of nonparticipants and potential screening barriers</article-title><source>Clin Lung Cancer</source><year>2020</year><month>09</month><volume>21</volume><issue>5</issue><fpage>e329</fpage><lpage>e336</lpage><pub-id pub-id-type="doi">10.1016/j.cllc.2019.11.016</pub-id><pub-id pub-id-type="medline">32371161</pub-id></nlm-citation></ref><ref id="ref35"><label>35</label><nlm-citation citation-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Pal</surname><given-names>A</given-names> </name><name name-style="western"><surname>Taneja</surname><given-names>N</given-names> </name><name name-style="western"><surname>Malhotra</surname><given-names>N</given-names> </name><etal/></person-group><article-title>Knowledge, attitude, and practice towards breast cancer and its screening among women in India: a systematic review</article-title><source>J Cancer Res Ther</source><year>2021</year><volume>17</volume><issue>6</issue><fpage>1314</fpage><lpage>1321</lpage><pub-id pub-id-type="doi">10.4103/jcrt.JCRT_922_20</pub-id><pub-id pub-id-type="medline">34916359</pub-id></nlm-citation></ref></ref-list></back></article>